Consolidated Balance Sheet (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Sep. 30, 2011
Current assets:
Cash and cash equivalents	$ 11,069	$ 16,980
Accounts receivable, less allowance for doubtful accounts of $106 and $110	33,107	30,350
Inventories, net	52,920	47,882
VAT Receivable	4,890	5,970
Other current assets	3,629	5,968
Total current assets	105,615	107,150
Property and equipment, net	206,812	215,083
Other assets	48	63
Total assets	312,475	322,296
Current liabilities:
Borrowings under credit lines	5,637	8,394
Trade accounts payable	12,701	13,643
Accrued expenses and other liabilities	8,684	7,925
Construction payables	1,675	1,027
Total current liabilities	28,697	30,989
Hungarian grant - allowance against future depreciation	6,741	7,765
Deferred tax liabilties	1,753	1,855
Liabilities carried at fair value		140
Total liabilities	37,191	40,749
Preferred stock, $.01 par value, 1,000,000 shares authorized, no shares issued and outstanding
Common stock, $.01 par value, 50,000,000 shares authorized, 34,368,192 shares issued and outstanding at December 31, 2011 and September 30, 2011	344	344
Additional paid-in capital	480,953	480,893
Accumulated other comprehensive loss	(57,575)	(41,549)
Accumulated deficit	(148,438)	(158,141)
Total shareholders' equity	275,284	281,547
Total liabilities and shareholders' equity	$ 312,475	$ 322,296